nav-left cat-right
cat-right

Kiadis BV and NV Organon Enter Into a Discovery Co...

GRONINGEN and OSS, The Netherlands, May 25 /PRNewswire/ — Kiadis BV and NV Organon announced today that both companies have entered into an evaluation agreement centered around the use of Kiadis’ core on-line screening technology, the BioSelact(TM), for the Reproductive Medicine discovery program at Organon. Under the terms of the collaboration, Organon will supply Kiadis with a proprietary target....

Odyssey Thera Initiates Project With Pfizer Inc.

SAN RAMON, Calif., May 17 /PRNewswire/ — Odyssey Thera, Inc. announced today an expanded agreement with Pfizer Inc. to profile compounds across Odyssey Thera’s panel of cell-based assays in order to characterize mechanism of action and pathway activity in human cells. Odyssey Thera’s patented Protein-fragment Complementation Assay (PCA) technology measures pathway activity within living cells and is applied...

GALAPAGOS NV & ASINEX LTD. INITIATE DRUG DISC...

Mechelen, Belgium & Moscow, Russia, 12 May 2005 – Galapagos NV, a genomics-based drug discovery company and ASINEX Ltd, a worldwide leader in lead generation and optimization announce that they have initiated an integrated drug discovery collaboration in bone and joint diseases. The collaboration will result in a set of optimized leads for Galapagos’ validated bone and joint disease drug targets. Financial...

Southern Research Institute Announces Joint Drug D...

BIRMINGHAM, Ala., May 9 /PRNewswire/ — Southern Research Institute today announced that it has entered into a joint collaborative research program with Schering-Plough Corporation (NYSE: SGP – News) to discover novel compounds as potential new products to treat infectious disease. Building on leads generated from Southern Research’s proprietary compound repository, scientists from both companies will...

Definiens and Cenix BioScience Enter Into Licensin...

The two companies’ offerings are ideally complementary and the agreement will therefore build on their inherent synergies. Cenix is providing research services for the life science industry and academic groups, focusing on the combination of high throughput (HT) RNAi with high content (HC) assays in human and rodent cells. For those groups capable of carrying out such large scale studies themselves, Definiens is...

LifePharms, Inc., Sloan-Kettering Institute, RTI I...

Groton, CT, New York, NY, and Research Triangle Park, NC.: April 7, 2005 – – As part of an effort to strengthen our nation’s bio-defenses against an outbreak of smallpox, LifePharms, Inc., the Sloan-Kettering Institute of Memorial Sloan-Kettering Cancer Center and The Natural Products Laboratory of RTI International have received a 5-year, $5 million research grant from the National Institute of Allergy...
Page 30 of 31« First...1020...2728293031